blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3595719

EP3595719 - LINKER UNITS AND MOLECULAR CONSTRUCTS COMPRISING SAME [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  25.08.2023
Database last updated on 17.09.2024
FormerExamination is in progress
Status updated on  16.12.2022
FormerRequest for examination was made
Status updated on  20.12.2019
FormerThe international publication has been made
Status updated on  22.09.2018
Most recent event   Tooltip25.08.2023Application deemed to be withdrawnpublished on 27.09.2023  [2023/39]
Applicant(s)For all designated states
Immunwork Inc.
18F., No.3, Park St.
Nangang District
Taipei City 115 / TW
[2020/04]
Inventor(s)01 / CHANG, Tse-Wen
13F., No. 21, Aly. 21, Ln. 98, Sec. 2
Academia Road
Nangang District
Taipei 115 / TW
02 / CHU, Hsing-Mao
1F., No. 47., Sec. 2,
Academia Road
Nangang District
Taipei 115 / TW
 [2020/04]
Representative(s)Lang, Christian
LangPatent Anwaltskanzlei IP Law Firm
Ingolstädter Straße 5
80807 München / DE
[N/P]
Former [2020/04]Lang, Christian
LangPatent Anwaltskanzlei
Ingolstädter Straße 5
80807 München / DE
Application number, filing date18767591.316.03.2018
[2020/04]
WO2018CN79301
Priority number, dateUS201762472011P16.03.2017         Original published format: US 201762472011 P
US201862613401P03.01.2018         Original published format: US 201862613401 P
[2020/04]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018166529
Date:20.09.2018
Language:EN
[2018/38]
Type: A1 Application with search report 
No.:EP3595719
Date:22.01.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 20.09.2018 takes the place of the publication of the European patent application.
[2020/04]
Search report(s)International search report - published on:CN20.09.2018
(Supplementary) European search report - dispatched on:EP30.11.2020
ClassificationIPC:A61K47/65, A61K47/64, A61K47/68, A61P35/00
[2021/01]
CPC:
A61K47/6889 (EP,IL,KR,US); C07K16/2809 (EP,IL,KR,US); A61K47/60 (IL,RU,US);
A61K47/65 (EP,IL,KR,RU,US); A61K47/64 (EP,IL,KR,RU,US); A61K47/6817 (IL,US);
A61K47/6849 (EP,IL,KR,US); A61K47/6859 (EP,IL,KR,US); A61K47/6867 (EP,IL);
C07K16/30 (IL,RU); C07K16/303 (IL,US); C07K2317/622 (EP,IL,KR,US) (-)
Former IPC [2020/04]A61K39/395, C12P21/08, C07K16/46
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/04]
TitleGerman:LINKEREINHEITEN UND MOLEKULARE KONSTRUKTIONEN DAMIT[2020/04]
English:LINKER UNITS AND MOLECULAR CONSTRUCTS COMPRISING SAME[2020/04]
French:UNITÉS DE LIAISON ET ASSEMBLAGES MOLÉCULAIRES LES COMPRENANT[2020/04]
Entry into regional phase13.09.2019National basic fee paid 
13.09.2019Search fee paid 
13.09.2019Designation fee(s) paid 
13.09.2019Examination fee paid 
Examination procedure13.09.2019Examination requested  [2020/04]
28.06.2021Amendment by applicant (claims and/or description)
16.12.2022Despatch of a communication from the examining division (Time limit: M04)
27.04.2023Application deemed to be withdrawn, date of legal effect  [2023/39]
24.05.2023Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2023/39]
Fees paidRenewal fee
28.07.2020Renewal fee patent year 03
10.03.2021Renewal fee patent year 04
10.03.2022Renewal fee patent year 05
10.03.2023Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO2015031268  (UNIV ARIZONA STATE [US], et al) [A] 1,2,5,7,8* figures 2A,5 *;
 [XDI]WO2016112870  (CHANG TSE-WEN [CN], et al) [XD] 1-4,6-15 * scheme 4 on page 74 * * scheme on page 76 * * scheme 8 on page 96 * * scheme 9 on page 97 * * scheme on page 98 * * scheme on page 99 * * scheme 12 on page 100 * * paragraphs [0034] - [0038] - [0040] , [0041] , [0076] - [0081] - [0083] - [0085] - [0109] - [0115] - [0125] * * paragraphs [0439] - [0441] - [0443] , [0445] , [0446] , [0448] - [0450] * * examples 1-46 * * claim - * [I] 5;
 [XI]WO2016184426  (CHANG TSE-WEN [CN], et al) [X] 1-4,6-8,11-13 * scheme 4 on page 52 * * scheme on page 54 * * scheme 8 on page 74 * * schemes 9 and 10 on page 75 * * scheme 11 on page 76 * * scheme 12 on page 77; page 3, lines 24-25 * * paragraphs [0028] , [0029] , [0057] , [0058] , [0074] , [0075] , [0155] , [0195] - [0197] - [0230] - [0232] - [0236] , [0239] , [0240] * * paragraph [0259] * * example - * * claim - * [I] 5,9,10,14,15;
 [XAI]WO2017036255  (CHANG TSE-WEN [CN], et al) [X] 1,2,6-8,12,13 * scheme 4 on page 44 * * scheme 5 on page 45 * * scheme 8 on page 63 * * schemes 9 and 10 on page 64 * * scheme 11 on page 65 * * paragraphs [0203] , [0207] , [0247] , [0248] , [0254] * * example - * * claim - * [A] 3,4,11 [I] 5,9,10,14,15;
 [XAI]WO2017036407  (CHANG TSE-WEN [CN], et al) [X] 1,2,6-8,12,13 * scheme 4 on page 41 * * scheme 5 on page 42 * * paragraphs [0024] , [0025] , [0106] - [0110] - [0169] , [0170] * * example - * * claim - * [A] 3,4,11 [I] 5,9,10,14,15;
 [E]WO2019057087  (CHANG TSE WEN [CN]) [E] 1-3,7,8,12,13 * page 23 * * paragraphs [0147] , [0152] - [0154] - [0200] - [0202] * * scheme 3 on page 25 * * claims 1,7-15 *
International search[A]WO2014153002  (CALIFORNIA INST BIOMEDICAL RES [US], et al) [A] 1-23 * claims 35, 36, 43 *;
 [A]WO2016112870  (CHANG TSE-WEN [CN], et al) [A] 1-23 * claims 1, 12, 13 *;
 [A]  - LI, W. L. et al., "New Advances in Bispecific Antibodies for Cancer Therapy", Chemistry of Life, (20101231), vol. 30, no. 6, pages 827 - 832, XP009504715 [A] 1-23
 [A]  - CAO, G. et al., "Antibody-Drug Conjugates", Progress in Chemistry, (20140225), vol. 26, pages 467 - 477, XP055465696 [A] 1-23

DOI:   http://dx.doi.org/10.7536/PC130650
 [A]  - ZHU, G. D. et al., "Design of Next Generation Antibody Drug Conjugates", Acta Pharmaceutica Sinica, (20131231), vol. 48, no. 7, pages 1053 - 1070, XP009504713 [A] 1-23
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.